A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

• Status: Completed
• Trial end date: 2008-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the comfort of Travatan Z in one eye and Xalatan in the opposite eye in patients with primary open-angle glaucoma or ocular hypertension.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Latanoprost; Ophthalmic Solutions; Pharmaceutical Solutions; Travoprost

Criteria

Inclusion Criteria:

• 18 years of age or older.

• Clinical diagnosis of ocular hypertension, primary open-angle, pigment dispersion, or exfoliation glaucoma in both eyes.

• Best corrected visual acuity of 20/200 Snellen or better in each eye.

• Intraocular pressure within protocol-specified range.

• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Any abnormality preventing reliable applanation tonometry in the study eye(s).

• Any eye conditions or procedures as specified in protocol.

• Progressive retinal or optic nerve disease from any cause.

• Use of contact lenses in the study eye(s).

• Other protocol-defined exclusion criteria may apply.